Quick Answer
BioCardia, Inc. reported Operating Income of -$8.28 million for fiscal year 2025.
BioCardia, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$8.28M | -3.5% |
| 2024 | -$8.00M | +31.3% |
| 2023 | -$11.64M | +2.2% |
| 2022 | -$11.90M | +5.8% |
| 2021 | -$12.63M | +18.7% |
| 2020 | -$15.53M | -9.3% |
| 2019 | -$14.21M | -0.8% |
| 2018 | -$14.10M | -13.7% |
| 2017 | -$12.40M | -63.1% |
| 2016 | -$7.61M | -40.7% |
| 2015 | -$5.41M | -2441.6% |
| 2014 | $231.0K | +2466.7% |
| 2013 | $9.0K | +102.7% |
| 2012 | -$339.0K | +45.1% |
| 2011 | -$618.0K | -6.0% |
| 2010 | -$583.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.49M | +15.3% | +27.5% |
| June 30, 2025 | -$2.05M | -24.4% | +24.8% |
| March 31, 2025 | -$2.73M | -19.8% | -55.2% |
| September 30, 2024 | -$1.76M | +32.4% | -6.5% |
| June 30, 2024 | -$1.65M | +52.2% | +27.5% |
| March 31, 2024 | -$2.27M | +35.2% | +12.4% |
| September 30, 2023 | -$2.60M | +15.1% | +24.7% |
| June 30, 2023 | -$3.45M | -38.3% | +1.7% |
- BioCardia, Inc. showed a decrease of -3.5% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, BioCardia, Inc.’s operating income has declined by 1319.9% (from -$583.0 thousand to -$8.28 million).
- The most recent figure is from BioCardia, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: